» Articles » PMID: 37389784

NLRP3 activation in Macrophages Promotes Acute Intestinal Injury in Neonatal Necrotizing Enterocolitis

Overview
Journal World J Pediatr
Specialty Pediatrics
Date 2023 Jun 30
PMID 37389784
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Macrophages are involved in various immune inflammatory disease conditions. This study aimed to investigate the role and mechanism of macrophages in regulating acute intestinal injury in neonatal necrotizing enterocolitis (NEC).

Methods: CD68, nucleotide-binding oligomerization domain, leucine-rich repeat, and pyrin domain-containing 3 (NLRP3), cysteine aspartate-specific protease-1 (caspase-1), and interleukin-1β (IL-1β) in paraffin sections of intestinal tissues from NEC and control patients were detected with immunohistochemistry, immunofluorescence, and western blot. Hypertonic pet milk, hypoxia and cold stimulation were used to establish a mouse (wild type and Nlrp3) model of NEC. The mouse macrophage (RAW 264.7) and rat intestinal epithelial cell-6 lines were also cultured followed by various treatments. Macrophages, intestinal epithelial cell injuries, and IL-1β release were determined.

Results: Compared to the gut "healthy" patients, the intestinal lamina propria of NEC patients had high macrophage infiltration and high NLRP3, caspase-1, and IL-1β levels. Furthermore, in vivo, the survival rate of Nlrp3 NEC mice was dramatically improved, the proportion of intestinal macrophages was reduced, and intestinal injury was decreased compared to those of wild-type NEC mice. NLRP3, caspase-1, and IL-1β derived from macrophages or supernatant from cocultures of macrophages and intestinal epithelial cells also caused intestinal epithelial cell injuries.

Conclusions: Macrophage activation may be essential for NEC development. NLRP3/caspase-1/IL-1β cellular signals derived from macrophages may be the underlying mechanism of NEC development, and all these may be therapeutic targets for developing treatments for NEC.

Citing Articles

Data-independent acquisition-based blood proteomics unveils predictive biomarkers for neonatal necrotizing enterocolitis.

Chen F, Tan K, Lv Z, Chen F, Xu W, Gong X Anal Bioanal Chem. 2024; 417(1):199-218.

PMID: 39562369 PMC: 11695561. DOI: 10.1007/s00216-024-05637-7.


Effect of tubastatin A on NLRP3 inflammasome activation in macrophages under hypoxia/reoxygenation conditions.

Li H, Liu C, Cui Y, Chang P, Chong W World J Emerg Med. 2024; 15(4):289-296.

PMID: 39050221 PMC: 11265631. DOI: 10.5847/wjem.j.1920-8642.2024.059.


Chromatin as alarmins in necrotizing enterocolitis.

Nofi C, Prince J, Wang P, Aziz M Front Immunol. 2024; 15:1403018.

PMID: 38881893 PMC: 11176418. DOI: 10.3389/fimmu.2024.1403018.

References
1.
Zhao X, Zhou J, Liang W, Sheng Q, Lu L, Chen T . Probiotics mixture reinforces barrier function to ameliorate necrotizing enterocolitis by regulating PXR-JNK pathway. Cell Biosci. 2021; 11(1):20. PMC: 7824920. DOI: 10.1186/s13578-021-00530-7. View

2.
van der Poll T, Shankar-Hari M, Wiersinga W . The immunology of sepsis. Immunity. 2021; 54(11):2450-2464. DOI: 10.1016/j.immuni.2021.10.012. View

3.
Nobs S, Kopf M . Tissue-resident macrophages: guardians of organ homeostasis. Trends Immunol. 2021; 42(6):495-507. DOI: 10.1016/j.it.2021.04.007. View

4.
Jiang T, Zhang H, Xu X, Li H, Yang J . Mixed probiotics decrease the incidence of stage II-III necrotizing enterocolitis and death: A systematic review and meta-analysis. Microb Pathog. 2019; 138:103794. DOI: 10.1016/j.micpath.2019.103794. View

5.
Al-Qazazi R, Lima P, Prisco S, Potus F, Dasgupta A, Chen K . Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2022; 206(5):608-624. PMC: 9716901. DOI: 10.1164/rccm.202110-2274OC. View